EGFR and neoplasm: An in-depth analysis of the tumor composition displayed a compliant expression pattern between EGFR and the epithelial marker CD326, whose levels decreased upon EGFR CAR T cell+IL-2 treatment indicating the highest tumor cell death in this cohort.